News

Zimmer Biomet to Host Fourth Quarter Earnings Conference Call

Zimmer Biomet to Host Fourth Quarter Earnings Conference Call

Zimmer Biomet Plans Earnings Conf Call This February

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a renowned leader in medical technology, has announced an important conference call to discuss its financial results for the fourth quarter. This event is scheduled for a live audio webcast on February 10, 2026, starting at 8:30 a.m. ET. The company will release its earnings report earlier that day at 6:30 a.m. ET, detailing its performance and other relevant financial metrics.

Accessing the Webcast

For interested individuals wishing to tune into the conference, the webcast will be accessible via Zimmer Biomet's Investor Relations website. Following the event, a replay will be made available, ensuring that stakeholders who could not attend the live session will have the opportunity to catch up on key insights shared during the presentation.

Joining the Call via Phone

Participants in the U.S. and Canada can join the conference call by dialing (800) 330-6710 and entering the conference ID 7090861. For international participants, the call can be accessed by dialing +1 (213) 279-1505, also using the same conference ID 7090861. This ensures that a wide audience can engage with the content delivered during the call.

About Zimmer Biomet

Zimmer Biomet has established itself as a leader in the global medical technology landscape, providing solutions that enhance patient mobility and improve overall health. The company boasts a comprehensive portfolio of innovative products and systems that are seamlessly integrated with digital and robotic technologies. Leveraging data analytics and artificial intelligence, Zimmer Biomet is dedicated to transforming the patient experience while supporting healthcare professionals across various settings.

Legacy of Innovation

With more than 90 years of experience in the industry, Zimmer Biomet is committed to delivering top-notch solutions that align with its vision for healthcare. The organization's culture is deeply rooted in continuous improvement, evolution, and innovation, helping it maintain a competitive edge in the rapidly changing medical landscape.

Exploring Zimmer Biomet's Portfolio

Zimmer Biomet's extensive offerings are designed to meet the diverse needs of healthcare providers and patients alike. Operating in over 25 countries and conducting sales in more than 100 countries, the company's influence on patient care and technological advancement reaches far and wide. With a robust commitment to quality, Zimmer Biomet continues to enhance its product range to ensure that it meets the highest standards of excellence.

Connecting with the Team

For individuals looking to learn more about Zimmer Biomet’s expansive product offerings, the company encourages visits to its website. Interested parties may also explore career opportunities within the organization through its dedicated platform, where they can find information on the company culture and available positions.

Frequently Asked Questions

What is the purpose of the fourth quarter earnings conference call?

The conference call aims to discuss Zimmer Biomet's financial results for the fourth quarter and provide insights into the company's performance.

When will the fourth quarter earnings call take place?

The earnings call is scheduled for February 10, 2026, at 8:30 a.m. ET.

How can I access the conference call?

Participants can access the call via phone or through the live audio webcast on the company's Investor Relations website.

Who can join the conference call?

Anyone interested in Zimmer Biomet's financial performance, including investors, analysts, and the general public, can join the call.

What is Zimmer Biomet's mission?

Zimmer Biomet's mission is to maximize patient mobility and improve health through innovative technology and solutions in the medical field.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 31

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 54

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 40

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 42

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Modine Expands Manufacturing Capacity with New Calgary Facility

Updated Category News Views 224

Modine Expands Manufacturing Capacity in Calgary Modine (NYSE: MOD), a prominent player in thermal management technology, has proudly opened a new state-of-the-art facility spanning 23,200m² (~250,000ft²) to enhance support for the rapidly increasing demand from data centers, especially within the hyperscale market. This facility is dedicated to the production of...

Continue Reading
Choice Hotels Champions Wildfire Relief with Donation Match Program

Updated Category News Views 221

Choice Hotels Champions Wildfire Relief with Donation Match Program In a heartfelt initiative, Choice Hotels International, Inc. (NYSE: CHH) has launched a campaign aimed at providing critical support to those affected by recent California wildfires. This effort focuses on empowering Choice Privileges members to contribute to the relief while amplifying their donations...

Continue Reading
APR Corp. Elevates K-Beauty Tech at CES 2025 for Global Reach

Updated Category News Views 645

APR Corp. Unveils Ambitious Plans for CES 2025 APR Corp. is set to make significant waves in the global beauty market by returning to CES for a second year, aiming to expand its presence internationally. Building on its successful launch at CES 2024, the beauty tech innovator is gearing up for CES 2025 with exciting new developments. Showcasing Innovative Beauty...

Continue Reading
Asia's B2B Payment Risks: Strain Lurks Beneath Stability

Updated Category News Views 7

Behind Asia's Facade of Stability Smile and wave, folks, because Asia's B2B credit scene ain't as rosy as the headlines might want you to believe. Sure, on the surface, things look stable, but dig a little deeper and there’s a whole heap of troubles brewing, especially for the smaller fry. It’s like watching a family portrait while the kids are bickering behind the...

Continue Reading
CYIOS Corporation Strengthens Investor Relations with New Partner

Updated Category News Views 145

CYIOS Corporation Engages Atlanta Capital Partners for IR Strategy CYIOS Corporation LLC (OTC: CYIO) is making strides in its investor relations approach by hiring Atlanta Capital Partners, LLC. This strategic move aims to enhance CYIOS's visibility in the financial market and streamline communications within the investment community. Introducing Atlanta Capital Partners...

Continue Reading